Daclatasvir dihydrochloride ID:1596
| Synonyms: |
| CAS NO : 1009119-65-6 |
|
| Molecular Formula: C40H50N8O6 |
| Molecular Weight: 738.88 |
| Purity: 98% |
| Solubility: In DMSO |
| Storage: -20°C |
Availability and Price
| |
If the item is temporarily out of stock. Please email to sales@betterbiochem.com,we will inform you when we have it in stock. |
| In Stock |
| |
 Order |
Remarks:Daclatasvir (USAN), also known as BMS-790052 and EBP-883 (trade name Daklinza), is NS5A inhibitor and a drug for the treatment of hepatitis C (HCV). It is was developed by Bristol-Myers Squibb and was approved in Europe on 22 August 2014. Daclatasvir inhibits the HCV nonstructural protein NS5A. Recent research suggests that it targets two steps of the viral replication process, enabling rapid decline of HCV RNA. Daclatasvir has been tested in combination regimens with pegylated interferon and ribavirin, as well as with other direct-acting antiviral agents including asunaprevir and sofosbuvir.
Quality Control
H-NMR,C-NMR,LC-MS,HPLC. |
|
Related Products
 Others |
